Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma

Abstract

Recurrent cancer genome aberrations are indicators of residing crucial cancer genes. Although recent advances in genomic technologies have led to a global view of cancer genome aberrations, the identification of target genes and biomarkers from the aberrant loci remains difficult. To facilitate searches of cancer genes in human hepatocellular carcinoma (HCC), we established a comprehensive protocol to analyze copy number alterations (CNAs) in cancer genomes using high-density single nucleotide polymorphism arrays with unpaired reference genomes. We identified common HCC genes by overlapping the shared aberrant loci in multiple cell lines with functional validation and clinical implications. A total of 653 amplicons and 57 homozygous deletions (HDs) were revealed in 23 cell lines. To search for novel HCC genes, we overlapped aberrant loci to uncover 6 HDs and 126 amplicons shared by at least two cell lines. We selected two novel genes, fibronectin type III domain containing 3B (FNDC3B) at the 3q26.3 overlapped amplicon and solute carrier family 29 member 2 (SLC29A2) at the 11q13.2 overlapped amplicon, to investigate their aberrations in HCC tumorigenesis. Aberrant up-regulation of FNDC3B and SLC29A2 occurred in multiple HCC data sets. Knockdown of these genes in amplified cells decreased cell proliferation, anchorage-independent growth, and tumor formation in xenograft models. Importantly, up-regulation of SLC29A2 in HCC tissues was significantly associated with advanced stages (P 5 0.0031), vascular invasion (P 5 0.0353), and poor patient survival (P 5 0.0325). Overexpression of FNDC3B or SLC29A2 in unamplified HCC cells promoted cell proliferation through activation of the signal transducer and activator of transcription 3 signaling pathway. Conclusion: A standardized genome-wide CNA analysis protocol using data from user-generated or public domains normalized with unpaired reference genomes has been established to facilitate high-throughput detection of cancer genes as significant target genes and biomarkers for cancer diagnosis and therapy. (HEPATOLOGY 2010;52:1690-1701 Abbreviations: ADAM15, a disintegrin and metallopeptidase 15; AKT, v-akt murine thymoma viral oncogene homolog 1; AMACR, alpha-methylacyl-coenzyme A racemase; BCAS1, breast carcinoma amplified sequence 1; BRMS1, breast cancer metastasis suppressor 1; CCND1, cyclin D1; CDKN2A, cyclin-dependent kinase inhibitor 2A; CHN2, chimerin 2; CKS1B, CDC28 protein kinase regulatory subunit 1B; CNA, copy number alteration; DAB2, disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila); EBV, Epstein-Barr virus; EGFR, epidermal growth factor receptor; ETV1, ets variant 1; EVI1, ecotropic viral integration site 1; FNDC3B, fibronectin type III domain containing 3B; HCC, hepatocellular carcinoma; HD, homozygous deletion; ICN, inferred copy number; IHC, immunohistochemistry; LRP1B, low-density lipoprotein receptor-related protein 1B; LRP5, low-density lipoprotein receptor-related protein 5; Luc, luciferase; MAGI2, membrane associated guanylate kinase, W...

HDAC Inhibitors Augmented Cell Migration and Metastasis through Induction of PKCs Leading to Identification of Low Toxicity Modalities for Combination Cancer Therapy

“…The culture conditions and authentication of cell lines were according to the previous report (20). Human liver (SNU-398, Huh6, HepG2, Hep3B, Huh7, PLC5, HCC36, TONG, HA59T, Sk-hep-1, HA22T, and Malhavu), lung (H358, H1437, H661, H226Br, H1299, CL1-3, CL1-0, H23, H928, and A549), gastric (NUGC, SC-M1, AZ521, AGS, and HR), and breast (MDA-231, Hs578T, and MCF-7) cancer cell lines were seeded into 6-cm dishes (1 Â 10 5 cells per dish) and cultured for 24 hours.…”

Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma

“…Amplification, upregulation and point mutations of LMCD1 in HCC To search for putative cancer-related genes in a highresolution genomic approach, we performed a genomewide DNA copy-number alteration study in multiple human cancer cell lines using Affymetrix 500K SNP GeneChip Arrays and used non-matched normal reference genomes as controls (Chen et al, 2010). The median smoothing method was used with a window size of five continuous single-nucleotide polymorphisms (SNPs) to minimize data variation and obtain the inferred copy number (ICN) of each SNP.…”

“…Analysis of copy-number alterations, gene expression and somatic mutation We performed copy-number alteration analysis using genomic data sets conducted using Affymetrix GeneChip Human Mapping 500K SNP Arrays and the dChip software as described previously (Chen et al, 2010). The LMCD1 expression level in clinical HCC tissues was analyzed by using multiple data sets downloaded from the iCOD database (Yoshida et al, 2010).…”

Identification and extensive analysis of inverted-duplicated HBV integration in a human hepatocellular carcinoma cell line

“…However, the effect of viral integration on host gene expression was not described. The 11q13 amplicon containing CCND1, cortactin (CTTN), and FGF genes is one of the most frequent amplification events in human tumors and is well characterized (20)(21)(22). FGF19 and CCND1 are invariably coamplified in HCCs, leading to an increase in expression of both genes.…”